Menu
Your Cart

Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)

Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)
Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)
Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)
Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)
Secured Shopping
Best security features
Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit (100uL x 6000 preps, Standard Edition)

Technology

Powered by Apostle MiniMax technology, Apostle MiniMax High Efficiency cfDNA Isolation Kit is an excellent tool for the isolation of ultra-low concentration cell free DNA (cfDNA).

Performance

The superb performance of Apostle MiniMax High Efficiency Cell-Free DNA Isolation Kit has been extensively validated. More examples of publications and performance data can be reviewed here [link].

Configuration

100uL x 6,000 preps

Cat #

A17622-600

Protocol (manual)

Download [pdf]

Protocol (automated)

Download [pdf]

Note: This product can be automated on an Apostle MagTouch Nucleic Acid Extraction Automation System, for details of the system, visit here [link].

Material Safety Data Sheet (MSDS)

United States English [pdf]

Other languages:

$5,767.20
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.